Reviewed by PillSeek Editorial Team · Last updated
About This Medication
This medication is a White Round 9 mm, Film coated extended release tablet with imprint "M;NE;30". It contains Nifedipine 30 mg; of Nifedipine[nifedipine];. This belongs to the Dihydropyridine calcium channel blocker pharmacologic class. It is manufactured by Mylan Pharmaceuticals Inc.. For details please contact your physician.
Basic Information
- Imprint
- M;NE;30
- Color
- White
- Shape
- Round
- Size
- 9 mm
Drug Information
- Strength
- Nifedipine 30 mg;
- Dosage Form
- Film coated extended release tablet
- RxCUI
- 198034
Pharmaceutical Classification
- Pharmacologic Class
- Dihydropyridine calcium channel blocker
Related Medications
Other drugs in the same class: Dihydropyridine Calcium Channel Blocker
- AmlodipineWHITE • ROUND
- amlodipine besylateamlodipine besylate 10 mg;WHITE • ROUND
- amlodipine besylateAMLODIPINE BESYLATE 10 mg;WHITE • ROUND
- amlodipine besylateAMLODIPINE BESYLATE 2.5 mg;WHITE • DIAMOND
- amlodipine besylateamlodipine besylate 5 mg;WHITE • ROUND
- amlodipine besylateAMLODIPINE BESYLATE 5 mg;WHITE • OCTAGON (8 SIDED)
- Amlodipine besylateAMLODIPINE BESYLATE 10 mg;WHITE • ROUND
- Amlodipine besylateAMLODIPINE BESYLATE 2.5 mg;WHITE • ROUND
- Amlodipine besylateAMLODIPINE BESYLATE 5 mg;WHITE • ROUND
- Amlodipine BesylateAMLODIPINE BESYLATE 10 mg;WHITE • ROUND
Ingredients
- Active Ingredients
- Nifedipine[nifedipine];
- Inactive Ingredients
- Silicon dioxide;hydroxypropyl cellulose, unspecified;hypromellose, unspecified;lactose monohydrate;magnesium stearate;polydextrose;polyethylene glycol, unspecified;titanium dioxide;triacetin;
Additional Information
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Status (Rx/OTC)
- Rx
- Brand Names
- Afeditab CR, Procardia
Browse Related Pills
⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.